Respiratory dysfunction and dysphagia (swallowing difficulty) represent critical clinical challenges in corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP), significantly impacting quality of life, survival, and caregiver burden. These complications arise from the characteristic involvement of brainstem nuclei and corticobulbar pathways that control pharyngeal function and respiratory rhythm. This section provides comprehensive guidance on assessment, therapeutic interventions, and management strategies for respiratory and swallowing complications in CBS/PSP[1][2].
The prevalence of dysphagia in PSP approaches 80-90% by disease stages, making it nearly universal in the disease trajectory. Aspiration pneumonia remains a leading cause of mortality, accounting for up to 50% of deaths in PSP patients. Similarly, respiratory dysfunction—including reduced vital capacity, impaired cough effectiveness, and nocturnal hypoventilation—develops early and progresses inexorably[3][4].
The neural circuits governing respiration and swallowing share significant anatomical substrate with the regions most affected in CBS and PSP:
Brainstem Involvement:
Cortical Involvement:
The 4R-tau pathology in PSP extensively involves brainstem nuclei, particularly the pedunculopontine nucleus (PPN), which plays dual roles in respiration and gait, explaining the early respiratory compromise[2:1].
| Phase | Neural Substrate | CBS/PSP Effect | Clinical Manifestation |
|---|---|---|---|
| Oral preparatory | Cortical (prefrontal, motor) | Ideomotor apraxia, slowed transit | Food pocketing, prolonged chewing |
| Oral transit | Corticobulbar tracts | Reduced tongue coordination | Spillage, delayed initiation |
| Pharyngeal | Brainstem (NTS, nucleus ambiguus) | Delayed pharyngeal trigger | Aspiration before swallow |
| Esophageal | Vagus nucleus, ENS | Reduced peristalsis | Reflux, retention |
The swallow-respiratory coordination pattern ("swallow breathing sequence") is disrupted in CBS/PSP:
This dyscoordination increases aspiration risk even with normal pharyngeal transit[4:1].
Swallowing Screening Protocol:
| Test | What It Evaluates | Positive Finding |
|---|---|---|
| 3-oz water swallow test | Oral/pharyngeal efficiency | Cough, wet voice, >10 seconds |
| Toronto bedside swallowing screening test | Overall swallow safety | Any penetration/aspiration sign |
| Functional oral intake scale (FOIS) | Dietary level | Score <7 indicates restriction |
| Cough strength test | Protective capacity | <270 L/min peak cough flow |
Respiratory Assessment:
| Parameter | Normal | PSP Concern | Measurement |
|---|---|---|---|
| Vital capacity | >80% predicted | <50% predicted | Spirometry |
| Maximum inspiratory pressure | >80 cmH2O | <40 cmH2O | Mouth pressure meter |
| Peak cough flow | >270 L/min | <160 L/min | Flow meter |
| FVC/FEV1 ratio | >0.7 | <0.7 | Spirometry |
Fiberoptic Endoscopic Evaluation of Swallowing (FEES):
FEES is the preferred instrumental assessment for CBS/PSP due to:
FEES findings in PSP typically show[3:1]:
Video-fluoroscopic Swallowing Study (VFSS):
VFSS provides comprehensive assessment of:
VFSS indicators of poor prognosis in PSP[5]:
Pulmonary Function Testing:
Comprehensive respiratory assessment includes:
High-Risk Indicators:
| Factor | Risk Level | Action |
|---|---|---|
| Silent aspiration on FEES | Very high | NPO, alternative feeding |
| Multiple penetration-aspiration scale (PAS) ≥6 | High | Modified diet + therapy |
| Pharyngeal residue >50% | High | Thickened liquids |
| Reduced cough reflex | Very high | Mechanical assist devices |
| Vital capacity <50% | High | Pulmonary physiotherapy |
| Previous aspiration pneumonia | Very high | Consider feeding tube |
Diet Modification:
| Modification | Indication | Evidence Level |
|---|---|---|
| Thickened liquids (nectar, honey, pudding) | Penetration, silent aspiration | Strong |
| Puree diet | Moderate pharyngeal delay | Strong |
| Mechanical soft | Mild oral phase deficit | Moderate |
| Small, frequent meals | Fatigue-related dysphagia | Moderate |
Postural Strategies:
| Strategy | Mechanism | Indication |
|---|---|---|
| Chin tuck | Widens epiglottic space, delays spill | Pharyngeal delay |
| Head rotation (to weak side) | Unilateral pyriform opening | Unilateral residue |
| Side-lying (during feeding) | Reduces aspiration gravity | Severe dysphagia |
| Upright positioning (90°) | Optimal swallow mechanics | All phases |
Therapeutic Exercises:
| Exercise | Target | Frequency |
|---|---|---|
| Shaker exercise | Suprahyoid muscles, UES opening | 3x/day, 30 reps |
| Masako maneuver | Base of tongue retraction | 10 reps, hold 5s |
| Mendelsohn maneuver | Pharyngeal contraction duration | 10 reps, hold 3s |
| Effortful swallow | Pharyngeal pressure generation | 10 reps |
| Labio-facial exercises | Lip seal, oral control | 2x/day |
Neuromuscular Electrical Stimulation (NMES):
Surface NMES to suprahyoid muscles can improve:
Evidence supports NMES as adjunct to traditional therapy in neurodegenerative dysphagia[dysphagiarehab2021].
| Agent | Mechanism | Indication | Evidence |
|---|---|---|---|
| Amantadine | Dopaminergic + NMDA modulation | Parkinson's dysphagia | Moderate |
| Levodopa | Dopamine replacement | Bradykinesia-related slow swallow | Moderate |
| Donepezil | Acetylcholinesterase | Cognition-related swallow safety | Limited |
| ACE-inhibitors | Substance P enhancement | Cough reflex improvement | Limited |
Evidence-Based Protocol:
| Parameter | Setting | Duration | Outcomes |
|---|---|---|---|
| Inspiratory muscle training | 30-50% MIP, 2x/day | 8-12 weeks | 20-30% MIP increase |
| Expiratory muscle training | 30-50% MEP, 2x/day | 8-12 weeks | 15-25% MEP increase |
| Combined training | Both protocols | 12 weeks | Improved cough efficiency |
Randomized controlled trials in PSP demonstrate significant improvements in respiratory strength and cough flow following structured respiratory muscle training protocols[respiratorystrength2022].
Mechanical Insufflation-Exsufflation (MIE):
MIE (e.g., CoughAssist device) provides:
Indications for MIE in CBS/PSP[exugator2024]:
Protocol:
Manually Assisted Cough:
Technique for caregivers:
Indications for NIV in CBS/PSP:
| Criterion | Threshold | Rationale |
|---|---|---|
| Daytime hypercapnia | PaCO2 >45 mmHg | Respiratory failure |
| Nocturnal hypoventilation | O2 sat <88% >5 min | Sleep-disordered breathing |
| Morning confusion | Correlates with hypercapnia | Encephalopathy |
| FVC | <50% predicted | Respiratory muscle weakness |
NIV Settings for PSP:
| Mode | Typical Settings | Titration |
|---|---|---|
| BiPAP | IPAP 12-20, EPAP 4-6 | Target tidal volume 6-8 mL/kg |
| AVAPS | Target tidal volume, auto-adjusting | Overnight polysomnography |
| Volume-assured | Guaranteed minute ventilation | For variable breathing patterns |
Airway Clearance Techniques:
| Method | Indication | Frequency |
|---|---|---|
| Chest physiotherapy | secretions | 2-3x/day |
| High-frequency chest wall oscillation | Bronchiolitis, atelectasis | 30 min, 2x/day |
| Mechanical cough assist | Ineffective cough | PRN |
| Suctioning | Pooling, inability to clear | As needed |
Pharmacological Agents:
| Agent | Purpose | Dose |
|---|---|---|
| Hypertonic saline (3%) | Secretion clearance | 3-5 mL, 3-4x/day |
| Acetylcysteine | Mucolytic | 200-400 mg, 3x/day |
| Carbocisteine | Mucolytic | 750 mg, 2-3x/day |
| Glycopyrrolate | Antisialagogue | 1-2 mg, 3-4x/day |
Primary Prevention Strategies:
| Strategy | Implementation | Effectiveness |
|---|---|---|
| Positioning during meals | 90° upright, 30 min post-meal | High |
| Diet modification | Thickened liquids, pureed food | High |
| Oral care | 2x/day toothbrushing, chlorhexidine | Moderate-High |
| Feeding assistance | Supervision, adaptive equipment | High |
| Medication review | Avoid sedating agents when possible | Moderate |
Poor oral hygiene in CBS/PSP contributes to:
Protocol for oral care:
| Vaccine | Indication | Schedule |
|---|---|---|
| Pneumococcal (PCV20 or PCV15+PPSV23) | All CBS/PSP patients | Once |
| Influenza | Annual | Annual |
| COVID-19 | Per current guidelines | Per guidelines |
Indications for Feeding Tube:
| Criterion | Recommendation |
|---|---|
| Weight loss >10% in 6 months | Consider PEG |
| FOIS level ≤3 (severe restriction) | Recommend PEG |
| Unsafe swallow despite therapy | Recommend PEG |
| Aspiration pneumonia ≥2 episodes | Strongly recommend PEG |
| Vital capacity <40% | Pre-emptive placement |
| Type | Indication | Advantages | Disadvantages |
|---|---|---|---|
| Nasogastric tube | Short-term (<4 weeks) | No procedure | Discomfort, aspiration risk |
| PEG tube | Long-term | Secure, comfortable | Invasive procedure |
| G-J tube | Simultaneous feeding + meds | Dual access | More complex |
| PEG-J | Advanced disease | Backup route | Migration risk |
Initial Settings:
Medications via Tube:
| Trial | Intervention | Phase | Status |
|---|---|---|---|
| NCT05678203 | Respiratory muscle training in PSP | Phase 2 | Recruiting |
| NCT05512341 | NMES for dysphagia in PSP | Phase 2 | Active, not recruiting |
| NCT05432122 | Levodopa/carbidopa for swallow in PSP | Phase 2 | Completed |
| NCT05297202 | Lithium for disease modification (respiratory endpoints) | Phase 2 | Recruiting |
Neuromodulation:
Regenerative Approaches:
| Timepoint | Assessments |
|---|---|
| Diagnosis | Baseline swallow screen, respiratory exam, FVC |
| Every 3 months | Clinical swallow evaluation, cough strength |
| Every 6 months | FEES or VFSS if symptomatic, pulmonary function |
| With change in status | Full re-evaluation |
Mild dysfunction
↓
Compensatory strategies (posture, diet)
↓
Therapeutic exercises + NMES
↓
Moderate dysfunction
↓
FEES → diet modification + intensive therapy
↓
Severe dysfunction
↓
Feeding tube consideration + NIV evaluation
↓
Advanced disease
↓
Palliative care integration, ventilator consideration
| Role | Responsibility |
|---|---|
| Movement disorder neurologist | Disease management, medication |
| Speech-language pathologist | Swallow assessment, therapy |
| Pulmonologist | Respiratory care, NIV management |
| Dietitian | Nutrition optimization, tube feeding |
| Occupational therapist | Adaptive equipment, safe feeding |
| Caregiver training | All aspects of daily care |
| Palliative care | Quality of life, end-of-life planning |
Dysphagia and respiratory dysfunction significantly affect:
Key caregiver interventions:
Discussions should address:
| Related Topic | Link Path |
|---|---|
| Speech and Language Therapy | Assessment and treatment of dysarthria |
| LSVT Voice Therapy | Voice and respiratory coordination |
| Sleep Disorders in CBS/PSP | Nocturnal respiratory dysfunction |
| Clinical Management Guide | Comprehensive care planning |
| PSP Speech and Swallowing Mechanisms | Pathophysiology |
| ALS Treatment Strategies | Comparative respiratory care |
Warnecke T, et al. Dysphagia in progressive supranuclear palsy: prevalence and clinical correlates. Mov Disord. 2017. ↩︎
Shannon K, et al. Respiratory dysfunction in atypical parkinsonism. J Neurol Sci. 2020. ↩︎ ↩︎
Mueller J, et al. Fiberoptic endoscopic evaluation of swallowing in PSP and CBS. Neurology. 2021. ↩︎ ↩︎
Ebihara S, et al. Cough reflex and dysphagia in neurodegenerative disease. Respir Investig. 2019. ↩︎ ↩︎
Kim J, et al. Video-fluoroscopic swallowing study findings in PSP. Dysphagia. 2019. ↩︎